Merck Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp3,300 (market cap 10.19T, 593.9K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 6× Merck Tbk.'s market cap, and Abadi Lestari Indonesia Tbk. is more actively traded (593.9K versus 37.6K). Which is the better fit depends on your goals.
| MERK | RLCO | |
|---|---|---|
Market Cap | 1.7T | 10.19T |
Volume | 37.6K | 593.9K |
Lot | 376 | 5.94K |
Turnover | 144.47M | 1.91B |
Average Price | 3,842.23 | 3,220.03 |
Value | 144.47M | 1.91B |
Indicative Equilibrium Price | 3,840 | 3,300 |
Indicative Equilibrium Volume | 7 | 87 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →